MENU
+Compare
TEVA
Stock ticker: NYSE
AS OF
Sep 26, 04:59 PM (EDT)
Price
$18.34
Change
-$0.02 (-0.11%)
Capitalization
21.66B

TEVA Teva Pharmaceutical Industries Limited Forecast, Technical & Fundamental Analysis

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world... Show more

TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TEVA with price predictions
Sep 25, 2025

TEVA sees its Stochastic Oscillator recovers from oversold territory

On September 23, 2025, the Stochastic Oscillator for TEVA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 59 instances where the indicator left the oversold zone. In of the 59 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 50-day moving average for TEVA moved above the 200-day moving average on September 16, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TEVA advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 224 cases where TEVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for TEVA moved out of overbought territory on September 15, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator moved out of overbought territory. In of the 45 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TEVA as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TEVA turned negative on September 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TEVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TEVA broke above its upper Bollinger Band on September 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TEVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.085) is normal, around the industry mean (16.880). P/E Ratio (0.000) is within average values for comparable stocks, (73.296). Projected Growth (PEG Ratio) (0.811) is also within normal values, averaging (1.947). TEVA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (1.266) is also within normal values, averaging (45.617).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TEVA is expected to report earnings to rise 2.27% to 67 cents per share on November 06

Teva Pharmaceutical Industries Limited TEVA Stock Earnings Reports
Q3'25
Est.
$0.68
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.03
The last earnings report on July 30 showed earnings per share of 66 cents, beating the estimate of 62 cents. With 4.96M shares outstanding, the current market capitalization sits at 21.66B.
A.I.Advisor
published Dividends

TEVA paid dividends on December 12, 2017

Teva Pharmaceutical Industries Limited TEVA Stock Dividends
А dividend of $0.09 per share was paid with a record date of December 12, 2017, and an ex-dividend date of November 27, 2017. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
124 Dvora HaNevi’a Street
Phone
+972 39148213
Employees
37851
Web
https://www.tevapharm.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JAVA68.560.49
+0.72%
JPMorgan Active Value ETF
HEGD24.750.10
+0.43%
Swan Hedged Equity US Large Cap ETF
WDTE33.630.03
+0.08%
Defiance S&P 500 Target 30 Income ETF
PBAP28.350.01
+0.04%
PGIM S&P 500 Buffer 20 ETF - Apr
DOG24.39-0.16
-0.65%
ProShares Short Dow30

TEVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TEVA has been loosely correlated with AMRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TEVA jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVA
1D Price
Change %
TEVA100%
-4.72%
AMRX - TEVA
41%
Loosely correlated
-1.13%
VTRS - TEVA
32%
Poorly correlated
-2.27%
ELAN - TEVA
29%
Poorly correlated
+0.91%
NBIX - TEVA
23%
Poorly correlated
-3.94%
OGI - TEVA
23%
Poorly correlated
-3.31%
More

Groups containing TEVA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVA
1D Price
Change %
TEVA100%
-4.72%
Pharmaceuticals: Generic
industry (224 stocks)
36%
Loosely correlated
+0.11%